AB Biotics

ab biotics logo

Contact information

AB Biotics, SA
Miquel Angel Bonachera / Sergi Audivert, CEO
Avinguda de la Torre Blanca, 57 ESADE Creapolis
Sant Cugat del Vallès
Barcelona
902903844
Areas of activity
  • A. Health Biotechnology
  • A. Health Biotechnology
  • Therapeutic areas
  • A. Health Biotechnology
  • Therapeutic areas
  • Cardiovascular diseases and circulatory system
  • A. Health Biotechnology
  • Therapeutic areas
  • Infectious diseases
  • A. Health Biotechnology
  • Therapeutic areas
  • Immunology
  • A. Health Biotechnology
  • Therapeutic areas
  • Oncology
  • A. Health Biotechnology
  • Therapeutic areas
  • Digestive system and hepatology
  • A. Health Biotechnology
  • Therapeutic areas
  • Central nervous system
  • A. Health Biotechnology
  • Areas of activity
  • A. Health Biotechnology
  • Areas of activity
  • In vitro diagnostics
  • B. Agrifood Biotechnology
  • B. Agrifood Biotechnology
  • Food
  • B. Agrifood Biotechnology
  • Food
  • Functional Food
  • C. Industrial Biotechnology
  • C. Industrial Biotechnology
  • Microorganism
  • D. Services
  • D. Services
  • R&D services
  • D. Services
  • R&D services
  • Genomics
  • D. Services
  • Professional services
  • D. Services
  • Professional services
  • Consultancy

Research, development, protection and distribution of our own biotechnological solutions, making a contribution to improve people health and wellbeing.

Products and services

AB-Biotics has two business divisions:

  • FUNCTIONAL INGREDIENTS develops probiotics and other nutraceuticals for the pharmaceutical and food sectors. Among them: AB-LIFE (probiotic for cardiovascular health), I3.1 (probiotic for IBD/IBS), AB-COLIC (probiotic for children colic) and AB-FORTIS (iron foritifcation).
  • AB-GENOTYPING develops genetic analyses for conducting pharmacogenetic studies. One of them is Neurofarmagen, already in the market. It is a DNA chip that enables the assessment of the patient?s predisposition to respond to the drugs most widely used in treating depression, schizophrenia, bipolar disorders or epilepsy.
Areas of interest for future collaborations

AB-BIOTICS is open to set up synergic partnerships with other companies in order to jointly develop new solutions. We look for partners interested in licensing our products to new markets.